Drugs / activated white blood cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01081223 | Apr 2010 → Mar 2011 | glioblastoma | TVAX Biomedical | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | activated white blood cells | “the activated white blood cells will be infused into the patient's bloodstream so that they will be able to attack the cancer.” NCT01081223 ↗ |
| Modality | Cell therapy | “the activated white blood cells will be infused into the patient's bloodstream so that they will be able to attack the cancer.” NCT01081223 ↗ |
| Route | Intravenous | “infused into the patient's bloodstream” NCT01081223 ↗ |